SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 91 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 6.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $54,000 | -63.3% | 45,000 | 0.0% | 0.00% | – |
| Q4 2021 | $147,000 | -67.1% | 45,000 | -55.0% | 0.00% | -100.0% |
| Q3 2021 | $447,000 | -18.0% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $545,000 | -27.1% | 100,000 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $748,000 | +225.2% | 100,000 | +284.9% | 0.00% | +100.0% |
| Q3 2020 | $230,000 | – | 25,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |